Certain immune cells acquired from a coronavirus that causes the common cold appear to react to COVID – but more so in children that adults.
Academic rigor, journalistic flair
Articles on Immunity
Displaying 1 - 20 of 145 articles
Less than half of the children aged 0-14 who have TB are diagnosed – so they never even start treatment.
Previous infection was highly protective against reinfection with alpha, beta and delta variants, but less so against omicron BA.1.
Scientists are trying to find out whether there’s a genetic reason certain people have managed to avoid COVID for three years.
A couple of theories are popular for explaining why we’re currently seeing very high levels of respiratory viruses, but they’re not based in science.
Amphibians have been devastated by a chytrid fungus pandemic. Researchers immunized California red-legged frogs in Yosemite to give them a fighting chance at survival, with surprising results.
During the 1918 flu pandemic, white people died at similar rates to Black Americans, according to a new study – a very different pattern than what occurred during the COVID-19 pandemic.
Strict lockdowns, quarantines and testing have prevented many people in China from catching COVID-19. With concerns over Chinese vaccine efficacy and uptake, China may be facing a looming COVID-19 surge.
You might not know you’ve had it. Or perhaps your immune system or genes have given you a boost. Or maybe you’re just lucky.
Lagging booster vaccine uptake in England means millions of people may not be optimally protected ahead of winter.
These types of vaccines could offer certain advantages over conventional COVID shots. But we need more data to show us they’re effective.
New research adds to scientists’ understanding of how invading pathogens can change the way our genes switch on and off.
German doctors have reported success in treating patients with severe lupus, using cell treatments like those used for some forms of blood cancer.
Evidence is growing there are changes to your immune system that may put you at risk of other infectious diseases.
New Zealand has done better than most countries by taking decisive action at the start of the COVID pandemic. Now is the time to build on this with a science-based strategy to manage the next stages.
The CDC’s endorsement of the reformulated COVID-19 booster shots represents a major step in the effort to get more Americans boosted.
There are two approved monkeypox vaccines in the US. Both use a related poxvirus called vaccinia to produce an immune response that protects against smallpox and monkeypox.
A new COVID variant, BA.2.75, has been detected in the UK and several other countries. But the data we have at the moment doesn’t suggest there’s any reason to panic.
Intuitively, we would assume that subsequent infections should be less severe. But this won’t always be the case.
‘Hybrid immunity’ is the term for immunity acquired from both prior infection and vaccination.
Top contributors
-
Professor of Immunology and Pro Vice-Chancellor, Research Partnerships, Victoria University
-
Associate Professor of Biology, Rochester Institute of Technology
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Research Fellow, Institute for Molecular Bioscience, The University of Queensland
-
Senior Lecturer; MD, Victoria University
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Research Leader in Virology and Infectious Disease, Griffith University
-
Research Officer - Immunology and Translational Research, Victoria University
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Virologist, Queen's University Belfast
-
Associate Professor, Epidemiology, Deakin University
